HIV Prevention Trials Network Launches HPTN 094 (INTEGRA) Study

Jun 9, 2021
HPTN 094 mobile van
One of five mobile health clinics deployed for the INTEGRA study. Artwork for the clinic was designed by artist Shepard Fairey.


The HIV Prevention Trials Network (HPTN) has launched HPTN 094 (INTEGRA), a study to determine whether using mobile health units to deliver integrated health services for people with opioid use disorder (OUD) can improve HIV and substance use treatment and prevention. This study is being conducted by the HPTN and is sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) with funding from the U.S. National Institute on Drug Abuse (NIDA), both part of the U.S. National Institutes of Health (NIH). Study products for HIV treatment and prevention are provided by Gilead Sciences, Inc.